Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neta Bar-Hai

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Pharmacology|August 29, 2022
Engaging plasticity: Differentiation therapy in solid tumorsNeta Bar-Hai, Dana Ishay-Ronen
Melanoma Research|June 24, 2024
Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapyNethanel Asher, Neta Bar-Hai, Guy Ben-Betzalel, et al.
Cancers|June 10, 2023
Better Late Than Never: The Impact of Steroidal Treatment on the Outcome of Melanoma Patients Treated with ImmunotherapyNeta Bar-Hai, Guy Ben-Betzalel, Ronen Stoff, et al.
Cells|September 14, 2024
Class Effect Unveiled: PPARγ Agonists and MEK Inhibitors in Cancer Cell DifferentiationRakefet Ben-Yishay, Opher Globus, Nora Balint-Lahat, et al.
Frontiers in Oncology|October 29, 2024
Modeling epithelial-mesenchymal transition in patient-derived breast cancer organoidsNeta Bar-Hai, Rakefet Ben-Yishay, Sheli Arbili-Yarhi, et al.
Brain : a Journal of Neurology|October 25, 2024
CCL2 blockade combined with PD-1/P-selectin immunomodulators impedes breast cancer brain metastasisSahar Israeli Dangoor, Rami Khoury, Koren Salomon, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|August 29, 2022
Engaging plasticity: Differentiation therapy in solid tumorsNeta Bar-Hai, Dana Ishay-Ronen
Melanoma Research|June 24, 2024
Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapyNethanel Asher, Neta Bar-Hai, Guy Ben-Betzalel, et al.
Cancers|June 10, 2023
Better Late Than Never: The Impact of Steroidal Treatment on the Outcome of Melanoma Patients Treated with ImmunotherapyNeta Bar-Hai, Guy Ben-Betzalel, Ronen Stoff, et al.
Cells|September 14, 2024
Class Effect Unveiled: PPARγ Agonists and MEK Inhibitors in Cancer Cell DifferentiationRakefet Ben-Yishay, Opher Globus, Nora Balint-Lahat, et al.
Frontiers in Oncology|October 29, 2024
Modeling epithelial-mesenchymal transition in patient-derived breast cancer organoidsNeta Bar-Hai, Rakefet Ben-Yishay, Sheli Arbili-Yarhi, et al.
Brain : a Journal of Neurology|October 25, 2024
CCL2 blockade combined with PD-1/P-selectin immunomodulators impedes breast cancer brain metastasisSahar Israeli Dangoor, Rami Khoury, Koren Salomon, et al.
Pageof 1